{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:49:13Z","timestamp":1793666953135,"version":"4.5.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine: X"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cytox.2020.100046","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T03:48:39Z","timestamp":1604116119000},"page":"100046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Humoral immunity in leishmaniasis \u2013 Prevention or promotion of parasite growth?"],"prefix":"10.1016","volume":"2","author":[{"given":"Ricardo","family":"Goncalves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Mosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/MMBR.00025-10","article-title":"Leprosy and the human genome","volume":"74","author":"Misch","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0015","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.cytox.2020.100046_b0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006164","article-title":"Changing demographics of visceral leishmaniasis in northeast Brazil: lessons for the future","volume":"12","author":"Lima","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.cytox.2020.100046_b0030","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/345772","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in Northeastern Brazil","volume":"186","author":"Turetz","year":"2002","journal-title":"J Infect Dis (Internet)"},{"key":"10.1016\/j.cytox.2020.100046_b0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: a literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop."},{"issue":"10151","key":"10.1016\/j.cytox.2020.100046_b0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet (London, England)."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1590\/S0036-46652006000300007","article-title":"Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control","volume":"48","author":"Dantas-Torres","year":"2006","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0050","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1016\/S0167-5699(05)80017-9","article-title":"Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function","volume":"12","author":"Locksley","year":"1991","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0060","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.168.5.1675","article-title":"Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens","volume":"168","author":"Scott","year":"1988","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.cytox.2020.100046_b0065","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis","volume":"88","author":"Heinzel","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0070","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0075","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0080","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830200528","article-title":"Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes","volume":"20","author":"Bogdan","year":"1990","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0085","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4049\/jimmunol.148.4.1182","article-title":"IL-4 induces a Th2 response in Leishmania major-infected mice","volume":"148","author":"Chatelain","year":"1992","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cytox.2020.100046_b0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in Leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cytox.2020.100046_b0095","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cytox.2020.100046_b0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20030159","article-title":"Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB\/c mice","volume":"198","author":"Von Stebut","year":"2003","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0110","doi-asserted-by":"crossref","first-page":"e0007865","DOI":"10.1371\/journal.pntd.0007865","article-title":"Lymphocytes influence Leishmania major pathogenesis in a strain-dependent manner","volume":"13","author":"Musa","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"issue":"12","key":"10.1016\/j.cytox.2020.100046_b0115","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1-type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect. Immun. [Internet]"},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/iai.62.3.837-842.1994","article-title":"Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis","volume":"62","author":"Melby","year":"1994","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1574-695X.2009.00607.x","article-title":"Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica","volume":"57","author":"Kumar","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.cytox.2020.100046_b0130","first-page":"239","article-title":"The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production","volume":"26","author":"Tapia","year":"1993","journal-title":"Biol. Res."},{"issue":"2","key":"10.1016\/j.cytox.2020.100046_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molimm.2013.08.008","article-title":"Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis","volume":"57","author":"Costa-Silva","year":"2014","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cytox.2020.100046_b0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cyto.2014.05.016","article-title":"In situ cytokines (IL-4, IL-10, IL-12, IFN-\u03b3) and chemokines (MCP-1, MIP-1\u03b1) gene expression in human Leishmania (Leishmania) Mexicana infection","volume":"69","author":"Valencia-Pacheco","year":"2014","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12413","article-title":"In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani","volume":"39","author":"Manamperi","year":"2017","journal-title":"Parasite Immunol."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0150","first-page":"16","article-title":"Interleukin-10 and transforming growth factor-\u03b2 in early and late lesions of patients with Leishmania major induced cutaneous Leishmaniasis","volume":"7","author":"Hejazi","year":"2012","journal-title":"Iran J Parasitol."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/515297","article-title":"Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major","volume":"177","author":"Louzir","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vaccine.2012.11.032","article-title":"The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas","volume":"31","author":"Bacon","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.cytox.2020.100046_b0165","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0170","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull. Soc. Pathol. Exot. Filiales"},{"issue":"52","key":"10.1016\/j.cytox.2020.100046_b0175","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.cytox.2020.100046_b0180","first-page":"35","article-title":"Advances in vaccine technology and their impact on managed care","volume":"33","author":"McCullers","year":"2008","journal-title":"P T."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0185","doi-asserted-by":"crossref","first-page":"e0005951","DOI":"10.1371\/journal.pntd.0005951","article-title":"Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis","volume":"11","author":"Cec\u00edlio","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0190","first-page":"205","article-title":"Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy","volume":"9","author":"Asherson","year":"1965","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0195","first-page":"469","article-title":"Desensitization in vitro\u2013the specific inhibition, by antigen, of the passive transfer of delayed hypersensitivity by peritoneal exudate cells","volume":"13","author":"Asherson","year":"1967","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0200","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4049\/jimmunol.118.3.809","article-title":"Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation","volume":"118","author":"Kaplan","year":"1977","journal-title":"J. Immunol."},{"issue":"5106","key":"10.1016\/j.cytox.2020.100046_b0205","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/2151202a0","article-title":"Tolerance in adult rats to a purified protein, flagellin, from Salmonella adelaide","volume":"215","author":"Parish","year":"1967","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/icb.1996.75","article-title":"Immune deviation: a historical perspective","volume":"74","author":"Parish","year":"1996","journal-title":"Immunol. Cell Biol."},{"issue":"6\u20137","key":"10.1016\/j.cytox.2020.100046_b0215","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-3083.1976.tb03034.x","article-title":"Immune complexes in human melanoma: a consequence of deranged immune regulation","volume":"5","author":"Jerry","year":"1976","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0220","first-page":"945","article-title":"Immune complexes in Indian kala-azar","volume":"60","author":"Sehgal","year":"1982","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.cytox.2020.100046_b0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0008-8749(86)90249-2","article-title":"Studies of tolerance in schistosomiasis","volume":"99","author":"McCurley","year":"1986","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0230","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"Chen","year":"1993","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0235","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0240","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.191.6.1063","article-title":"Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis","volume":"191","author":"Kima","year":"2000","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0245","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/IAI.73.4.2101-2108.2005","article-title":"Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions","volume":"73","author":"Buxbaum","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cytox.2020.100046_b0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-6632.1998.tb11094.x","article-title":"Evolution of serum albumin\/globulin ratio after antimonial therapy in canine leishmaniasis","volume":"849","author":"Amusategui","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-4894(86)90187-6","article-title":"Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys","volume":"61","author":"Dennis","year":"1986","journal-title":"Saimiri sciureus. Exp Parasitol."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0260","first-page":"265","article-title":"Visceral leishmaniasis in immunocompromised: diagnostic and therapeutic approach and evaluation of the recently released IDSA guidelines","volume":"24","author":"Pagliano","year":"2016","journal-title":"Le Infez Med."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.cytox.2020.100046_b0270","first-page":"1005","article-title":"Disseminated Leishmania infantum infection in two sibling foxhounds due to possible vertical transmission","volume":"49","author":"Gibson-Corley","year":"2008","journal-title":"Can Vet J = La Rev Vet Can."},{"issue":"2","key":"10.1016\/j.cytox.2020.100046_b0275","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/iai.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.cytox.2020.100046_b0280","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/eji.1830220813","article-title":"Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation","volume":"22","author":"Basak","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"9102","key":"10.1016\/j.cytox.2020.100046_b0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(97)04350-X","article-title":"Rapid accurate field diagnosis of Indian visceral leishmaniasis","volume":"351","author":"Sundar","year":"1998","journal-title":"Lancet (London, England)."},{"issue":"3\u20134","key":"10.1016\/j.cytox.2020.100046_b0290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1574-695X.1996.tb00141.x","article-title":"Dog-DAT: a direct agglutination test using stabilized, freeze-dried antigen for the serodiagnosis of canine visceral leishmaniasis","volume":"16","author":"Oskam","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"9","key":"10.1016\/j.cytox.2020.100046_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004992","article-title":"Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion","volume":"10","author":"Christensen","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.cytox.2020.100046_b0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fimmu.2012.00301","article-title":"Protective and pathologic immune responses in human tegumentary leishmaniasis","volume":"3","author":"Carvalho","year":"2012","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0305","doi-asserted-by":"crossref","first-page":"e0007152","DOI":"10.1371\/journal.pntd.0007152","article-title":"Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis","volume":"13","author":"Christensen","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0310","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.185.11.1977","article-title":"Selective suppression of interleukin-12 induction after macrophage receptor ligation","volume":"185","author":"Sutterwala","year":"1997","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cytox.2020.100046_b0315","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.4049\/jimmunol.166.11.6861","article-title":"Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors","volume":"166","author":"Gerber","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0320","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.4049\/jimmunol.0802703","article-title":"The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages","volume":"182","author":"Edwards","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cytox.2020.100046_b0325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1189\/jlb.2A1114-560R","article-title":"The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling","volume":"98","author":"Fleming","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.cytox.2020.100046_b0330","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytox.2020.100046_b0335","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.1901382","article-title":"Immune complex-driven generation of human macrophages with anti-inflammatory and growth-promoting activity","volume":"205","author":"Dalby","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytox.2020.100046_b0340","first-page":"1","article-title":"Segunda nota sobre a vacinacao preventiva na leishmaniose tegumentar americana com leptomonas mortas","volume":"19","author":"Pessoa","year":"1941","journal-title":"Rev. Paul. Med."},{"issue":"4","key":"10.1016\/j.cytox.2020.100046_b0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0035-9203(79)90159-7","article-title":"A field trial of a vaccine against american dermal leishmaniasis","volume":"73","author":"Mayrink","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.cytox.2020.100046_b0350","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.4049\/jimmunol.129.5.2206","article-title":"Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection","volume":"129","author":"Howard","year":"1982","journal-title":"J. Immunol."},{"issue":"7788","key":"10.1016\/j.cytox.2020.100046_b0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytox.2020.100046_b0360","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/iai.64.6.2206-2215.1996","article-title":"Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b\/CD18) and complement receptor type 1 (CD35) in promastigote adhesion","volume":"64","author":"Rosenthal","year":"1996","journal-title":"Infect. Immun."},{"issue":"46","key":"10.1016\/j.cytox.2020.100046_b0365","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine."},{"issue":"43","key":"10.1016\/j.cytox.2020.100046_b0370","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcel\u00e9n","year":"2009","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.cytox.2020.100046_b0375","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","author":"Velez","year":"2020","journal-title":"Trop. Med. Int. Health"}],"container-title":["Cytokine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590153220300264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590153220300264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:37:09Z","timestamp":1762915029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590153220300264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2590153220300264"],"URL":"https:\/\/doi.org\/10.1016\/j.cytox.2020.100046","relation":{},"ISSN":["2590-1532"],"issn-type":[{"value":"2590-1532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immunity in leishmaniasis \u2013 Prevention or promotion of parasite growth?","name":"articletitle","label":"Article Title"},{"value":"Cytokine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytox.2020.100046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100046"}}